MDGL MADRIGAL PHARMACEUTICALS, INC.: institutional ownership and insider trading
450 funds reported holding $15.4B of MADRIGAL PHARMACEUTICALS, INC. in their latest 13F filings; in Q2 2026 funds net bought $40.0M, with 74 new positions and 42 funds selling out; over the last 12 months insiders bought $0 and sold $81.5M on the open market.
Famous investors holding MDGL
- Ken Griffin (Citadel Advisors): $369M, 0.0% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $87.1M, 0.0% of the portfolio
- Renaissance Technologies (Renaissance Technologies): $24.7M, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $63.6M, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $5.62M, 0.0% of the portfolio
Largest institutional holders of MDGL
- BAKER BROS. ADVISORS LP — $1.15B
- RTW INVESTMENTS, LP — $1.07B
- VANGUARD GROUP INC — $1.05B
- JANUS HENDERSON GROUP PLC (JHG) — $1.05B
- Jupiter Topco LLC — $1.04B
- Avoro Capital Advisors LLC — $984M
- PAULSON & CO. INC. — $720M
- BlackRock, Inc. (BLK) — $645M
- VANGUARD CAPITAL MANAGEMENT LLC — $449M
- WELLINGTON MANAGEMENT GROUP LLP — $443M
Recent MDGL insider trades
- Sep 11, 2026: Sibold William John sold 11,583 shares ($6.24M)
- Aug 17, 2026: Kelley Shannon T sold 664 shares ($342K)
- Jul 20, 2026: Sibold William John sold 2,500 shares ($1.37M)
- Jun 1, 2026: Soergel David sold 1,042 shares ($517K)
5%+ owners
- JANUS HENDERSON GROUP PLC: 8.8% (Schedule 13G/A, filed May 15, 2026)
- PAULSON & CO. INC.: 6.1% (Schedule 13G/A, filed May 15, 2026)